Skip to main content
Atrás
NNCSF logo

Nanosonics Limited

Calidad de datos: 100%
Sobreventa
NNCSF
OTC Healthcare Medical - Instruments & Supplies
$2.19
▼ $0.11 (-4.78%)
Cap. Mercado: 664.36M
Rango del Día
$2.19 $2.19
Rango de 52 Semanas
$2.14 $3.30
Volumen
100
Promedio 50D / 200D
$2.70 / $2.73
Cierre Anterior
$2.19

Quick Summary

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (631 pares)

Métrica Acción Mediana del Sector
P/E 32.1 0.3
P/B 3.2 3.0
ROE % 10.6 3.7
Net Margin % 10.4 3.8
Rev Growth 5Y % 18.2 10.0
D/E 0.0 0.2

Precio Objetivo de Analistas

No hay cobertura de analistas disponible

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2030 $0.00
$0.00 – $0.00
 379.10M 0
FY2029 $0.13
$0.13 – $0.14
 295.47M 1
FY2028 $0.09
$0.09 – $0.10
 275.45M 1

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-24 $0.04 $0.02 -46.2%
2025-08-24 $0.02 $0.02 +16.8%
2025-02-19 $0.01 $0.02 +46.7%
2024-08-26 $0.01 $0.01 +27.2%
2024-02-26 $0.01 $0.01 +51.3%
2023-06-30 $0.01 $0.02 +54.3%
2022-12-31 $0.02 $0.02 +12.6%
2022-06-30 -$0.01 $0.00 +97.8%

Dividend History

Yield

0.00%

Payout Ratio

N/A

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

Puntos Clave

Revenue grew 18.22% annually over 5 years — strong growth
Earnings grew 59.39% over the past year
ROE of 10.55% — decent returns on equity
Debt/Equity of 0.04 — conservative balance sheet
Generating 35.26M in free cash flow
P/E of 32.13 — premium valuation

Crecimiento

Revenue Growth (5Y)
18.22%
Revenue (1Y)17.01%
Earnings (1Y)59.39%
FCF Growth (3Y)33.64%

Calidad

Return on Equity
10.55%
ROIC3.08%
Net Margin10.39%
Op. Margin4.49%

Seguridad

Debt / Equity
0.04
Current Ratio5.66
Interest Coverage6.10

Valoración

P/E Ratio
32.13
Forward P/EN/A
P/B Ratio3.16
EV/EBITDA57.22
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 17.01% Revenue Growth (3Y) 8.97%
Earnings Growth (1Y) 59.39% Earnings Growth (3Y) 1.97%
Revenue Growth (5Y) 18.22% Earnings Growth (5Y) 24.60%
Profitability
Revenue (TTM) 198.93M Net Income (TTM) 20.68M
ROE 10.55% ROA 7.59%
Gross Margin 78.25% Operating Margin 4.49%
Net Margin 10.39% Free Cash Flow (TTM) 35.26M
ROIC 3.08% FCF Growth (3Y) 33.64%
Safety
Debt / Equity 0.04 Current Ratio 5.66
Interest Coverage 6.10
Dividends
Dividend Yield 0.00% Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 32.13 Forward P/E N/A
P/B Ratio 3.16 P/S Ratio 3.34
PEG Ratio 0.84 Forward PEG N/A
EV/EBITDA 57.22 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 5.31%
Market Cap 664.36M Enterprise Value 510.75M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 198.93M 170.01M 167.52M 119.73M 101.83M
Net Income 20.68M 12.97M 19.88M 3.74M 8.58M
EPS (Diluted) 0.07 0.04 0.06 0.01 0.03
Gross Profit 155.66M 132.44M 125.66M 86.15M 74.91M
Operating Income 8.93M 9.12M 18.00M 792,000.0 8.38M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 272.48M 237.34M 226.08M 193.24M 164.58M
Total Liabilities 62.57M 55.14M 62.22M 54.55M 29.01M
Shareholders' Equity 209.91M 182.20M 163.86M 138.69M 135.57M
Total Debt 7.69M 9.30M 10.72M 11.71M 2.49M
Cash & Equivalents 161.29M 129.55M 112.16M 94.51M 96.03M
Current Assets 225.32M 198.45M 181.24M 150.50M 142.15M
Current Liabilities 39.79M 32.23M 33.03M 28.64M 19.54M

Puntuaciones de Estrategias

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#858 of 1052
29

Actividad Reciente

Entró Cash Flow Compounder
Mar 24, 2026